Skip to main content

Imanol Otaegui Irurueta

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Imanol Otaegui Irurueta

Institutions of which they are part

Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Eficacia y seguridad de la doble antigregación comparada con aticoagulación oral+doble antiagregación en pacientes con fibrilación auricular de bajo-moderado riesgo sometidos a la implantación de un stent coronario

IP: Antonia Sambola Ayala
Collaborators: J. Bruno Montoro Ronsano, Bernat Serra Creus, Gerard Marti Aguasca, Imanol Otaegui Irurueta, Bruno García del Blanco, Pilar Tornos Mas
Funding agency: Ministerio Sanidad
Funding: 408000
Reference: TRA-200
Duration: 01/01/2010 - 31/12/2014

Patologia Cardiocirculatòria

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Antonia Sambola Ayala, Nuria Rivas Gandara, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Artur Evangelista Masip, Elsa Nieto Santa, Josep Pinar Sopena, Teresa González Alujas, Enric Domingo Ribas, Jaume Sagristà Sauleda, Aida Ribera Sole, Santiago Aguade Bruix, Rosa María Lidón Corbi, Gerard Marti Aguasca, Imanol Otaegui Irurueta, Ignasi Barba Vert, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 56160
Reference: 2009 SGR 802
Duration: 01/01/2010 - 30/04/2014

Protección miocárdica durante la reperfusión pacientes síndrome coronario agudo con elevación del segmento ST sometidos a angioplastia primaria: efecto de la adenosina intracoronaria sobre el tamaño del infarto y remodelado ventricular

IP: -
Collaborators: José Antonio Barrabés Riu, Antonia Sambola Ayala, Artur Evangelista Masip, Teresa González Alujas, Rosa María Lidón Corbi, Imanol Otaegui Irurueta, Bruno García del Blanco, Mireia Andres Villarreal, Mª Ángeles Carmona Ramírez
Funding agency: Instituto de Salud Carlos III
Funding: 461010
Reference: EC07/90511
Duration: 01/11/2007 - 30/06/2012

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Juan Fernando Pacheco Paramo

Juan Fernando Pacheco Paramo

Tècnic/a Superior Recerca
Core Facilities Area
Read more
Alberto Morales Galan

Alberto Morales Galan

Research technician
Cardiovascular Diseases
Read more
Cristina de Dios Conde

Cristina de Dios Conde

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
Core Facilities Area
Read more
Maria Roca Herrera

Maria Roca Herrera

Predoctoral researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.